INTRODUCTION: Inflammation is crucially involved in a variety of diseases like autoimmune syndromes, cardiovascular and neurodegenerative disorders, cancer, sepsis and allograft rejection. METHODS: Freshly isolated human peripheral blood mononuclear cells (PBMCs) are used as a screening assay for anti-inflammatory properties of compounds. Determinations of neopterin production by ELISA and of tryptophan degradation by HPLC are used as read-outs. Results are compared with further markers of immune response and oxidative stress. RESULTS: Phytohaemagglutinin induced significant tryptophan degradation and neopterin formation in PBMC, which correlated with IFN-γ, TNF-α, soluble cytokine receptors and isoprostane-8. Addition of vitamin C and E suppressed the responses dose-dependently. DISCUSSION: The determination of tryptophan degradation and neopterin production in PBMC reflects various pro- and anti-inflammatory cascades that are of relevance also in patients. It constitutes a robust and reliable approach to screen anti-inflammatory or immunosuppressive drugs and may improve throughput, speed and cost-effectiveness in drug discovery.
INTRODUCTION: Inflammation is crucially involved in a variety of diseases like autoimmune syndromes, cardiovascular and neurodegenerative disorders, cancer, sepsis and allograft rejection. METHODS: Freshly isolated human peripheral blood mononuclear cells (PBMCs) are used as a screening assay for anti-inflammatory properties of compounds. Determinations of neopterin production by ELISA and of tryptophan degradation by HPLC are used as read-outs. Results are compared with further markers of immune response and oxidative stress. RESULTS: Phytohaemagglutinin induced significant tryptophan degradation and neopterin formation in PBMC, which correlated with IFN-γ, TNF-α, soluble cytokine receptors and isoprostane-8. Addition of vitamin C and E suppressed the responses dose-dependently. DISCUSSION: The determination of tryptophan degradation and neopterin production in PBMC reflects various pro- and anti-inflammatory cascades that are of relevance also in patients. It constitutes a robust and reliable approach to screen anti-inflammatory or immunosuppressive drugs and may improve throughput, speed and cost-effectiveness in drug discovery.
Authors: Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde Journal: Nat Med Date: 2003-09-21 Impact factor: 53.440
Authors: Gabriele Neurauter; Anna V Grahmann; Martin Klieber; Alain Zeimet; Maximilian Ledochowski; Barbara Sperner-Unterweger; Dietmar Fuchs Journal: Cancer Lett Date: 2008-08-12 Impact factor: 8.679
Authors: C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter Journal: J Exp Med Date: 1984-07-01 Impact factor: 14.307
Authors: Susanne Kuehnl; Sebastian Schroecksnadel; Veronika Temml; Johanna M Gostner; Harald Schennach; Daniela Schuster; Stefan Schwaiger; Judith M Rollinger; Dietmar Fuchs; Hermann Stuppner Journal: Phytomedicine Date: 2013-07-15 Impact factor: 5.340
Authors: Johanna M Gostner; Emanuel Raggl; Kathrin Becker; Florian Überall; Harald Schennach; James E Pease; Dietmar Fuchs Journal: Immunol Lett Date: 2015-10-22 Impact factor: 3.685
Authors: Johanna M Gostner; Katrin Becker; Heinz Kofler; Barbara Strasser; Dietmar Fuchs Journal: Int Arch Allergy Immunol Date: 2016-05-04 Impact factor: 2.749
Authors: Johanna M Gostner; Sebastian Schröcksnadel; Kathrin Becker; Marcel Jenny; Harald Schennach; Florian Uberall; Dietmar Fuchs Journal: FEBS Open Bio Date: 2012-08-17 Impact factor: 2.693
Authors: M A Sunil; V S Sunitha; Prasanthkumar Santhakumaran; Mohind C Mohan; Midhun Sebastian Jose; E K Radhakrishnan; Jyothis Mathew Journal: Inflammopharmacology Date: 2021-06-11 Impact factor: 4.473